Fullerton Fund Management’s AbbVie ABBV Stock Holding History

Fullerton Fund Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$403K	Sell	1,603 -2,856	-64%	-$614K	0.03%	82
2026 Q1	$970K	Buy	+4,459	New	+$989K	0.08%	41
2025 Q4	–	Sell	-6,025	Closed	-$1.4M	–	125
2025 Q3	$1.4M	Buy	6,025 +4,318	+253%	+$879K	0.05%	41
2025 Q2	$317K	Buy	1,707 +134	+9%	+$24.9K	0.01%	86
2025 Q1	$330K	Buy	+1,573	New	+$306K	0.02%	96
2024 Q4	–	Sell	-4,793	Closed	-$947K	–	95
2024 Q3	$947K	Buy	4,793 +61	+1%	+$11.4K	0.04%	60
2024 Q2	$812K	Hold	4,732	–	–	0.04%	55
2024 Q1	$862K	Buy	+4,732	New	+$816K	0.04%	54

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fullerton Fund Management's ABBV Position: Q2 2026 in Review

Fullerton Fund Management reduced its AbbVie (ABBV) stake by 64% in Q2 2026, selling an estimated $614K and leaving 1,603 shares worth $403K. The position accounts for 0.03% of the portfolio, ranked #82.

Fullerton Fund Management first reported a position in ABBV in Q1 2024 and has held it in 8 quarters since. The position peaked at $1.4M in Q3 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Fullerton Fund Management held 1,603 shares of AbbVie worth $403K as of Q2 2026.
Fullerton Fund Management sold 2,856 AbbVie shares in Q2 2026, an estimated $614K.
AbbVie made up 0.03% of Fullerton Fund Management's portfolio in Q2 2026, its #82 holding.
Fullerton Fund Management first reported a position in AbbVie in Q1 2024 and has held it in 8 quarters since.
Fullerton Fund Management's AbbVie position peaked at $1.4M in Q3 2025.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Fullerton Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.